Evive Biotech is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide. We leverage our proprietary technology platforms to advance a series of innovative drug candidates for oncology, inflammatory and metabolic diseases.
Founded in 2004, we currently have operations in the US, Singapore, and China. As the first biopharmaceutical company to build a platform bringing innovative therapies from China to the world, Evive adopts a holistic approach to drug development, combining exceptional research and commercialization capabilities with our world-class in-house regulatory expertise and extensive international management experience.
Through partnerships with industry, physicians, and regulatory authorities, we strive to bring revolutionary remedies to the global market quickly and efficiently to address unmet medical needs, making a real and lasting difference to patients and their families worldwide.
To learn more, visit www.evivebiotech.com.
Company Details
- Employees
- 36
- Founded
- -
- Address
- Singapore, Sg
- Industry
- Biotechnology
- Website
- evivebiotech.com
- HQ
- Singapore
Evive Biotech Questions
Evive Biotech's website is evivebiotech.com
Evive Biotech's LinkedIn profile is https://www.linkedin.com/company/evive-biotech
Evive Biotech has
36 employees.
View email and phone details for 36
employees at Evive Biotech.
Evive Biotech's industry is
Biotechnology
Evive Biotech's top competitors are
Day One Biopharmaceuticals,
Scigen Pte. Ltd.,
Biogen,
Cellares,
Twist Bioscience,
Beigene,
Ptc Therapeutics, Inc.,
Shanghai Junshi Biosciences Co Ltd,
Gilead Sciences,
Novo Nordisk.
Evive Biotech's categories are Biotechnology
Evive Biotech's founding year is 2004
